Cravath Publishes Winter 2026 Issue of Alumni Journal
January 08, 2026
Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $3.5 billion of credit facilities made available to Genmab, a leading international biotechnology company, and one of its wholly‑owned subsidiaries, Genmab Finance LLC, as part of the financing transactions undertaken in connection with its acquisition of Merus N.V., a leading oncology company developing innovative antibody therapeutics. The credit facilities consisted of a $2 billion term loan “B” facility, a $1 billion term loan “A” facility and a $500 million revolving credit facility. The transaction closed on December 12, 2025.
Cravath also represented the initial purchasers in connection with the Rule 144A/Reg. S offering of $1.5 billion senior secured notes and $1 billion senior unsecured notes of Genmab and Genmab Finance LLC. The transaction closed on December 3, 2025.
The Cravath team included partners Craig F. Arcella, Isaac C. Beerman and Kelly M. Smercina, of counsel D. Ana Choi and associates Trevor Lutzow, Lauri Marjamaki, Gabriela Flores‑Romo, Yeana Lee and Tiancheng Lyu on capital markets and financing matters; partner Arvind Ravichandran and associate Frederick Schemel on tax matters; partners Sasha Rosenthal-Larrea and David J. Kappos and associates Callum A.F. Sproule and M. Noa Ma on intellectual property matters; partner Matthew Morreale on environmental matters; partner Chris Medley and associate Amrit Singh Gill on non‑U.S. collateral matters; practice area attorney Lauren Piechocki on real estate matters; and associate S. Celine Li on executive compensation and benefits matters. Helen T. Yang also worked on capital markets and financing matters.
Deals & Cases
February 20, 2026
Cravath represented First Solar, Inc. in connection with its $1.5 billion revolving credit facility. First Solar is America’s leading photovoltaic solar technology and manufacturing company, and the only US‑headquartered company among the world’s largest solar manufacturers. The transaction closed on February 13, 2026.
Deals & Cases
December 24, 2025
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with $3.2 billion of revolving credit facilities made available to Ameren Corporation and Union Electric Company (the “Missouri Borrowers”) and Ameren Corporation and Ameren Illinois Company (the “Illinois Borrowers”). Ameren Corporation is an American power company that engages in the rate‑regulated electric generation, transmission and distribution activities; and rate‑regulated natural gas distribution and transmission businesses. The facilities consisted of a $1.9 billion revolving credit facility (Missouri Borrowers) and $1.3 billion revolving credit facility (Illinois Borrowers). The transaction closed on December 10, 2025.
Deals & Cases
November 24, 2025
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with a $2 billion revolving credit facility made available to Thomson Reuters Corporation, a leading AI and technology company empowering professionals with trusted content and workflow automation. The transaction closed on November 10, 2025.
Deals & Cases
October 30, 2025
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with a $4 billion revolving credit facility made available to Valero Energy Corporation, a leading multinational manufacturer and marketer of petroleum‑based and low‑carbon liquid transportation fuels and petrochemical products. The transaction closed on October 16, 2025.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2026 Cravath, Swaine & Moore LLP.